Dr. Scott Charles Leverage, MD

Dr. Leverage practices at Tri-State Digestive Disorder Center in Crestview Hills, Kentucky.

Dr. Leverage's NPI, 1700064995, was assigned on February 10, 2008. Dr. Leverage graduated from Wright State University Boonshoft School of Medicine in 2005. Dr. Leverage holds Kentucky license 41822.

Dr. Leverage's primary practice is Tri-State Digestive Disorder Center, at 425 Centre View Boulevard, Crestview Hills, KY 41017. The practice phone is (859) 341-3575.

Dr. Leverage's primary practice is Tri-State Digestive Disorder Center in Crestview Hills, Kentucky. Dr. Leverage is also affiliated with St. Elizabeth Healthcare Edgewood Hospital. The medical group on file is Tri-State Gastroenterology Associates. Dmand AI also links Dr. Leverage to 3 more hospitals, each named with a free account. Dr. Leverage's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leverage practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Leverage's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Leverage is licensed in Kentucky.

CMS data shows 808 Medicare services from Dr. Leverage across 13 procedure codes in 2024, for 424 Medicare patients. Medicare paid $70,499 for them.

CMS counts 424 Medicare patients who saw Dr. Leverage in 2024. The largest group is 65 to 74, with 231 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Leverage's median patient age at 66, with 58% women.

In 2024, Dr. Leverage wrote 1,485 Medicare Part D claims for 474 patients. 76% of them were for generic drugs. CMS names the drug for 1,319 of them, across 25 drugs with 11 or more claims each, at $406,352 in total drug cost. In 2023, CMS named 1,244 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Leverage for performance year 2024, reported through an alternative payment model (APM). Dr. Leverage accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 139 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Leverage, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Leverage, published from 2011 to 2012. The most frequent topics are Fatty Liver and Non-alcoholic Fatty Liver Disease.

CMS Open Payments shows 647 general payments to Dr. Leverage from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $2,072.

Dr. Leverage graduated from Wright State University Boonshoft School of Medicine in 2005.